Professor Maria Kavallaris inducted into AIMBE College of Fellows

01 Apr 2025

Leading childhood cancer researcher, Professor Maria Kavallaris AM, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, one of the highest professional distinctions accorded to medical and biological engineers worldwide. 

Head of the Translational Cancer Nanomedicine Group at Children's Cancer Institute, and founding Director of the Australian Centre for NanoMedicine at the University of NSW, Professor Kavallaris, attended the induction ceremony in person in Virginia, USA, on 31 March. 

Elected by peers and members of the College of Fellows “for pioneering advances in cancer biology that led to new technologies and strategies for identification and delivery of therapeutic agents,” Professor Kavallaris said she was proud to see her contributions acknowledged in this way. 

"Being inducted into the AIMBE College of Fellows is a profound honour for me. This recognition of my work at the interface of cancer, chemistry and engineering is incredibly meaningful, and it motivates me to continue pushing the boundaries of medical and biological engineering. I am grateful for the support of my lab members, collaborators and peers and excited about the future advancements we can achieve together."

One of the first scientists to join the Institute when its laboratories opened in 1984, Professor Kavallaris has become internationally renowned in the field of childhood cancer research and has made several world-first discoveries. She is particularly well known for her groundbreaking research into clinical drug resistance, targeted therapies, and the application of nanotechnology to cancer treatment.  

She has received many prestigious awards for her work. In 2019 she was appointed a Member of the Order of Australia for her significant service to medicine and medical research in the field of childhood and adult cancers, and in 2020 she was named NSW Premier’s Woman of the Year.